DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK.
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Nat Med 2004; 10 (2): 145-7
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.